About FDA

Rare Diseases Program

Mission Statement:

To facilitate, support and accelerate the development of drug and biologic products for the benefit of patients with rare disorders.

Overview:

  • Coordinate the development of CDER policy, procedures and training for the review of treatments for rare diseases.
  • Assist in outside development and maintenance of good science as the basis for the development of treatments for rare diseases.
  • Work collaboratively with external and internal rare disease stakeholders to promote the development of treatments for rare disorders.
  • Maintain collaborative relationships with CDER's review divisions to promote consistency and innovation in the review of treatments for rare disorders.
  • Work collaboratively with international regulatory agencies to discuss and exchange scientific and regulatory information related to rare diseases.

Page Last Updated: 08/09/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English